Prolongation of nerve block duration

Prolongation of nerve block duration refers to efforts to increase the time that a nerve block—a local anesthetic intervention that prevents nerve signal transmission—remains effective. This outcome is typically achieved by co-administering certain adjunct drugs (such as dexamethasone, dexmedetomidine, epinephrine, buprenorphine, clonidine, or magnesium) with local anesthetics[1][5][7][8][9]. These adjuncts are not the 'target' themselves; rather, they act upon molecular targets (commonly voltage-gated sodium channels for local anesthetics) or modulate nerve conduction via other mechanisms to prolong anesthetic action. Therefore, 'prolongation of nerve block duration' is not a valid molecular or receptor target. In summary, the provided target name refers to a clinical objective, not a definable molecule, protein, receptor, or gene. If detailed structured data are needed, the query should specify an actual molecule or receptor implicated in nerve block mechanisms, such as 'Voltage-gated sodium channel type 1 subunit alpha' or 'Alpha-2 adrenergic receptor'.

This outcome is achieved by co-administering certain adjunct drugs with local anesthetics. These adjuncts act upon molecular targets (commonly voltage-gated sodium channels for local anesthetics) or modulate nerve conduction via other mechanisms to prolong anesthetic action.